Professional Documents
Culture Documents
asked questions
on
MR vaccination-
campaign
• All children who have completed 9 months of age and are below
15 years of age regardless of previous vaccination status with
measles/rubella vaccine and regardless of measles/rubella
infection in the past
• Malnourished children should be vaccinated on a priority basis, as
they are more likely to have complications like diarrhea and
pneumonia
• Children with minor illnesses such as mild respiratory infection,
diarrhea, and low grade fever
Rubella vaccine is being given as a combined vaccine i.e. Measles-Rubella (MR) vaccine.
For eliminating measles, two doses are required which are given at 9-12 months and 16-
24 months. Therefore, MR vaccine will also be given as two dose schedule. As per WHO
position paper on Rubella “An RCV is normally administered as a subcutaneous injection,
usually at age 12–15 months, but it can also be administered to children aged 9–11
months and to older children, adolescents and adults. In some countries, rubella vaccine
is given as MR or MMR, and the age of administration follows the schedule for measles –
that is, the first dose is usually given at 9 months or 12–15 months and a second dose at
15–18 months or 4–6 years”
The maternal antibodies for both measles and rubella also wanes to a significant level
after 9 months of age, so also reducing the antibody interference, thus making the child
susceptible to both measles and rubella infection. Rubella vaccine efficacy has also been
proven to be above 90% when given at 9-12 months of age. Thus there is no harm in
giving rubella vaccine at 9 months of age, as this protects the child from both measles and
rubella disease.
If a male child develops rubella there is a chance that he may infect other
individuals like a pregnant mother which may result in Congenital Rubella
Syndrome. Thus, it is important that everyone is protected against rubella. If male
children are not protected, then the transmission of rubella virus will not stop and
continues to circulate among male children. Those constitute nearly 50 percent
population and enough to sustain ongoing rubella transmission leading to
outbreaks. This sustained rubella transmission in the community is a potential
threat to antenatal mothers in early pregnancy, living in the family and community.
So, if we do not stop transmission in the population, we cannot control or
eliminate rubella/CRS in our country.
A 14 year old girl is having menses. Should the girl get the
MR vaccine during campaign?
• Yes,
• In JE endemic districts, both MR and JE vaccine should be
given together at the same time but on different arms.
• When for any reason vaccines couldn’t be given at the same
time/day, then a minimum gap of 4 weeks has to be
maintained as a standard practice between any two live
vaccines.
Slight pain and tenderness at the site of injection may occur within 24 hours, sometimes followed by
mild fever.
About 7–12 days after vaccination, up to 5% of measles vaccine recipients may experience fever of at
least 39.4 °C for 1–2 days. The fever may occasionally (1 in 3,000 injections) induce febrile seizures.
A transient rash may occur in about 2% of vaccinated children.
Thrombocytopenic purpura occurs in approximately 1 in 30,000 vaccinated individuals.
Arthralgia/ Joint pain can also occur when given in adolescent children or adults.
Anaphylaxis is a very rare event that can happen in 1 in 1- 3 million MR vaccine doses, for which
there is an AEFI management kit available for use by the trained medical officers during the campaign.
Adverse events, with the exception of anaphylactic reactions, are less likely to occur after receipt of a
second dose of MR containing vaccine.
All districts have prepared campaign micro-plan and also formed AEFI
committees. The district officials will make sure that all the session sites
are linked to the nearest AEFI management centres. In addition, all the
medical officers will be trained in management of AEFI and all the session
sites will have contact details of the AEFI centres including a specially
prepared AEFI Management kit.
• Yes.
• According to the Immunization Schedule, the MR vaccine
needs to be administered as MR-1 at 9-12 months of age
and MR-2 at 16–24 months
Yes, the government has sent letters to Indian Academy of Paediatrics (IAP) and
Indian Medical Association (IMA) to participate in the MR campaign. The private
practitioners, who will be participating in the campaign, will be provided with the
MR vaccine; and at the end of each day they will have to submit the report of
children vaccinated and vaccines and logistics received and utilized. They will have
to follow the MR campaign guidelines laid by the GOI and State Government.
Parents can opt for private practitioners but will have to show the duly filled
vaccination card for the MR campaign to the MR campaign team.
Encourage other parents with children in the target age group to participate
in the MR campaign and complete the child’s RI schedule as per the
immunization schedule